Published: 1 October 2025
Lumasiran (Oxlumo) has been listed on the PBS schedule from 1 October 2025.
Due to the medicine’s high cost, claims for lumasiran will be paid in 2 payments to PBS approved suppliers.
The first payment will be made through PBS Online, with the second payment a manual bulk adjustment for the balance.
Claims for lumasiran will be monitored. PBS approved suppliers will get both payments within their usual payment timeframes.
This information was printed 22 October 2025 from https://www.servicesaustralia.gov.au/new-medicine-added-to-pharmaceutical-benefits-scheme-pbs. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/site-notices when using this material.